Jordan S. Farrell is a doctoral candidate at the University of Calgary, Canada SUMMARY A recent article by Farrell et al. characterizes the phenomenon, mechanisms, and treatment of a local and severe hypoperfusion/hypoxia event that occurs in brain regions following a focal seizure. Given the well-established role of cerebral ischemia/ hypoxia in brain damage and behavioral dysfunction in other clinical settings (e.g., stroke, cerebral vasospasm), we put forward a new theory: postictal hypoperfusion/hypoxia is responsible for the negative consequences associated with seizures. Fortunately, inhibition of two separate molecular targets, cyclooxygenase-2 (COX-2) and L-type calcium channels, can prevent the expression of postictal hypoperfusion/hypoxia. These inhibitors are important experimental tools used to separate the seizure from the resulting hypoperfusion/hypoxia and can allow researchers to address the contribution of this phenomenon to negative outcomes associated with seizures. Herein we address the implications of this postictal stroke-like event in acute behavioral dysfunction (e.g., Todd's paresis) and sudden unexpected death in epilepsy (SUDEP). Moreover, anatomic alterations such as increased blood-brain barrier permeability, glial activation, central inflammation, and neuronal loss could also be a consequence of repeated hypoperfusion/hypoxic events and, in turn, underlie chronic interictal cognitive and behavioral comorbidities (e.g., memory deficits, anxiety, depression, and psychosis) and exacerbate epileptogenesis. Thus these seemingly disparate and clinically important observations may share a common point of origin: postictal hypoperfusion/ hypoxia.
The Postictal Hypoperfusion/ Hypoxia Phenomenon in People with Epilepsy and Experimental Models
Previous studies that examined blood flow during the postictal period in persons with epilepsy yielded inconsistent observations, with some reporting local hypoperfusion [1] [2] [3] and others local hyperperfusion. [4] [5] [6] To better understand postictal perfusion, Farrell et al. 7 systematically measured local blood flow following brief electrically evoked hippocampal seizures in rats. They reported a~50% drop in local blood flow that lasted more than an hour in that same structure. This sustained perfusion deficit was found to be mediated by local vasoconstriction of hippocampal arterioles. These results then informed a clinical investigation that used arterial spin-labeling (ASL) magnetic resonance imaging (MRI) to measure postictal perfusion at 1 h following spontaneous seizures in 10 persons with epilepsy. A comparable magnitude decrease in cerebral blood flow was observed. Furthermore, the severity of hypoperfusion positively correlated with seizure duration. The scans confirmed that postictal hypoperfusion was localized to brain areas expressing seizure activity, but also indicated that the rat hippocampal kindling model yielded results that were equivalent to the condition in humans.
Farrell et al. 7 also precisely measured local brain tissue oxygenation levels in rodents with a chronically implanted optode system. Because the brain consumes 20% of the body's oxygen to meet its high energy demands 8 and cerebral hypoxia is known to cause injury and impairments, 9 measuring the local partial pressure of oxygen (pO 2 ) gives important insight into the detrimental effects of reduced blood flow. During typical behavioral states, hippocampal pO 2 levels vary within the normoxia range between 18 and 30 mm Hg. However, following a brief seizure, local pO 2 levels dropped below 10 mm Hg, often for more than an hour in several commonly used seizure models. The severity of hypoxia was correlated positively with seizure duration, similar to blood flow. Notably, pO 2 <10 mm Hg is considered severely hypoxic and associated with poorer outcomes after brain injury 10 and with induction of hypoxia-dependent gene expression. 11 The striking severity and duration of hypoxia led us to question how it could impact brain structure and function and to what extent postictal hypoperfusion/ hypoxia explains the detrimental effects associated with seizures.
A Model of the Mechanisms of Postictal Hypoperfusion/ Hypoxia and its Prevention
To experimentally determine the impact of postictal hypoperfusion/hypoxia on brain function there was a need to pharmacologically prevent this phenomenon without affecting seizure expression. Farrell et al. 7 tested a wide variety of compounds that possessed different mechanisms of action and discovered two drug targets that when blocked, prevented postictal hypoxia without significantly altering seizure duration: cyclooxygenase-2 (COX-2) and L-type calcium channels.
COX-2 is a postsynaptic enzyme that catalyzes the first step in generating the vasoactive prostanoids (prostaglandin-D2, E2, F2a, prostacyclin, and thromboxane). from arachidonic acid, 12 although other fatty acids are also substrates for COX-2. 13, 14 The prostanoids exert their effects through G protein-coupled receptors and, when expressed on vascular smooth muscle, can modulate vessel diameter. The prostanoid(s) and receptor(s) that mediate vasoconstriction are still unknown. Downstream of COX-2, Farrell et al. 7 also showed that L-type calcium channels, which are found on smooth muscle that coats arterioles, are key downstream targets, since blocking these channels also inhibits severe postictal hypoxia.
Another way to look at these two mechanisms is from a temporal perspective. Preseizure administration of COX-2 or L-type calcium channel antagonists blocked postictal hypoxia. 7 However, when COX-2 antagonists were administered immediately following termination of the seizures they were completely ineffective. On the other hand, L-type calcium channel blockers given immediately following the seizure were just as effective at blocking postictal hypoxia as preseizure administration. Thus COX-2 induction is recruited during seizure activity and is upstream of L-type calcium channels, which are then recruited to mediate longlasting vasoconstriction.
We present a model ( Fig. 1 ) in which, following sustained synaptic activity, neuronal COX-2 rapidly oxygenates its substrates to vasoactive products. These products then move from the neuron to act on receptors located on vascular smooth muscle, thereby facilitating L-type calcium channel conductance and allowing extracellular calcium to enter. The elevated cytosolic calcium in smooth muscle then engages the molecular machinery that mediates vasoconstriction.
With the temporal kinetics of these mechanisms in mind, a few administration paradigms exist to prevent postictal hypoperfusion/hypoxia. In an experimental setting where seizures are induced, COX-2 inhibitors can be administered before the seizure. However, in models of spontaneous seizures and clinical settings where seizure prediction is not possible, COX-2 inhibitors need to be given chronically to ensure that the drug is present during seizure activity. These drug administration paradigms (preseizure or chronic) also work with L-type calcium channel blockers, but immediate postseizure drug delivery is also an option. Immediate postseizure administration of L-type calcium channel antagonists is not only valuable when seizure prediction is not feasible, but has the added experimental benefit of not potentially affecting seizure characteristics. Armed with our current understanding of the mechanisms involved in postictal hypoperfusion/hypoxia and knowledge of how and when to use inhibitors to prevent its manifestation, we now have powerful experimental tools. The following is a In animal models or people with seizures, subjects can be placed into two main groups: (1) seizures with hypoperfusion/hypoxia (placebo/vehicle) or (2) seizures without hypoperfusion/hypoxia (COX-2 or L-type calcium channel inhibitors). To reveal if the inhibitor's effect is due to preventing hypoperfusion/hypoxia following seizures or an unrelated effect of the drug, other comparison groups should also be examined such as groups of nonseizure subjects who receive placebo/vehicle or the inhibitors. Moreover, any positive benefit seen with one drug could be due to that drug's other mechanisms of action (e.g., COX-2's antiinflammatory effects). Thus experimental approaches should use both drugs to strengthen claims that the effects are due to their anti-postictal hypoperfusion/hypoxia effects and not due to off-target effects. Because the inhibitors of COX-2 and inhibitors of L-type calcium channels do not have overlapping mechanisms of action they are ideally suited for these experiments. Given the well-documented effects of ischemia/hypoxia on brain structure and function, [9] [10] [11] it is reasonable to suggest that local tissue hypoperfusion/hypoxia in the postictal period has profound impacts on brain structure and function. Thus we put forward a theory that postictal hypoperfusion/hypoxia is responsible for the negative consequences associated with seizures. A key strength of this theory is that it gives rise to a set of context specific hypotheses that are testable and refutable. The theory is limited to the consequences of postictal hypoperfusion/hypoxia and does not make predictions about the role of blood flow, 15 hypoxia, 16 or any other causal agents in seizure initiation or seizure termination.
We have articulated a strong version of the theory that postictal hypoperfusion/hypoxia is responsible for the negative consequences associated with seizures. We did this to provide a clear and assailable target for future experimentation. Much like T.P. Sutula's theory that mossy-fiber sprouting served as the basis of epileptogenesis 17 got softened over the decades in the light of new experimentation, this theory may go that route, or not. Only testing of specific hypotheses derived from the theory will answer that question. Our theory gives rise to a set of hypotheses that are testable and refutable, and serve as starting point for future research.
Below we examine some of the detrimental aspects of seizures that could be explained by postictal hypoperfusion/hypoxia. For each section, we provide a brief synopsis of the feature and the evidence for vascular insufficiency as an explanation for its occurrence. Finally we tie together these different detrimental consequences of seizures to create a unified theory that could guide future research (Fig. 2) . Two key molecular targets mediating postictal hypoperfusion/hypoxia. An excitatory synapse is shown in proximity to a local arteriole. Following sustained synaptic activity during a seizure, postsynaptic calcium accumulates and increases the activity of COX-2, which enzymatically converts its substrates to several yetto-be-determined lipid-signaling molecules. One or more of these products act on receptor(s) located on vascular smooth muscle opening L-type calcium channels, which leads to vasoconstriction. Epilepsia ILAE Acute Behavioral Dysfunction (e.g., Todds Paresis, Amnesia, Confusion, Psychosis)
Seizures are associated with disrupted sensory, cognitive, or motor function. Although chronic behavioral dysfunction occurs interictally and persists, acute postictal impairments are confined to the period following a seizure and eventually resolve. In the short period immediately before, during, and a minute or so after a seizure (periictal), the behavioral disruptions are likely a reflection of local network activity caused by the oncoming expression and immediate consequences of the hypersynchronous and hyperexcitable electrical event (seizures). Following the periictal electroencephalography (EEG) suppression, low-frequency EEG returns but behavioral dysfunction can persist for tens of minutes to hours to days (postictal). These postictal impairments are the topic of interest in this section, not to be confused with periictal or interictal behavioral changes.
Todd's paresis represents an exemplary case to best relate postictal behavioral impairments to hypoperfusion/hypoxia. Robert Bentley Todd 18 provided the first detailed description of postictal paresis, which later came to bear his name. Todd's paresis, as originally described, is significant regional limb weakness following seizure activity in the contralateral motor cortex, which can last minutes to hours to days before a full recovery is made. The obvious similarities to ischemic stroke, in fact, often lead to misdiagnosis. 19 Indeed, case studies revealed regional hypoperfusion of motor cortex during Todd's paresis. 19, 20 This provides merit to the hypothesis that Todd's paresis, and other acute brain structure specific postictal behavioral impairments, are the direct result of localized hypoperfusion/hypoxia. This hypothesis has been tested using electrical kindling to model focal seizures in rats. 7 Farrell et al. 7 studied two postictal behaviors: forelimb weakness following seizures elicited in motor cortex and novel object memory formation following seizures elicited in the hippocampus. After motor seizures, they observed decreased forelimb strength, as measured by duration on the hanging bar task that recovered when rats were no longer hypoxic. Furthermore, pretreatment with an L-type calcium channel inhibitor (nifedipine) prevented this deficit without altering seizure duration. These results were echoed in the hippocampal study in which rats subjected to postictal hypoperfusion/hypoxia during the time of memory encoding could not distinguish between novel and familiar objects on the subsequent test day. Pretreatment with a COX antagonist (acetaminophen) to prevent hypoperfusion/hypoxia averted this postictal amnesia. 7 In both experiments, the results supported the theory that acute postictal behavioral disruptions result from local hypoperfusion/hypoxia, and not the seizure per se. Future research could aim to determine the extent of brain structure specific postictal behavioral impairments explained by this phenomenon and provide clinical validation.
Sudden Unexpected Death in Epilepsy (SUDEP)
An extreme example of acute behavioral disruption that could be related to postictal hypoperfusion/hypoxia 
is a phenomenon termed sudden unexpected death in epilepsy (SUDEP). It is estimated that 5-8% of individuals with epilepsy die suddenly and unexpectedly with no identifiable cause of death, 21 a rate that is 24 times higher compared to nonepileptic populations. Although no underlying mechanism of death has yet been identified, many cases of SUDEP share defining characteristics. It is notable that SUDEP is strongly linked to the occurrence of a seizure, particularly a generalized tonicclonic seizure (GTCS). The single greatest risk factor for SUDEP is a high frequency of GTCS. 22 In the rare event that SUDEP is witnessed, a tonic-clonic seizure is usually observed shortly before death, and in unwitnessed SUDEP cases evidence of a recent seizure is often present. 23 The strongest evidence to date that SUDEP events are the consequence of a seizure comes from the landmark MORTality in Epilepsy Monitoring Unit Study (MORTEMUS), in which all 11 SUDEP deaths recorded in an epilepsy monitoring unit occurred 2.5-16 min after a GTCS. 24 This timing of sudden death in the postictal period is consistent with the temporal profile of the postictal hypoxia/hypoperfusion phenomenon.
Although several theories of the pathophysiology that underlies SUDEP exist, breathing cessation followed by cardiac arrest is particularly well supported. One indication that respiratory dysfunction plays a role in SUDEP is that when cases are witnessed, the individual is observed having difficulty breathing prior to death. 25 In addition, the MOR-TEMUS study found breathing failure to be the precipitating event leading to death in all monitored SUDEP cases, with terminal apnea occurring 2.8-8.8 min before terminal cardiac arrest.
We propose a neurobiologic mechanism of SUDEP whereby forebrain seizures propagate to respiratory nuclei in the brainstem, producing local vasoconstriction and local hypoxia postictally. This hypoxia would trigger a cascade of pathologic events including dysfunction of neuronal networks responsible for breathing and respiratory rhythm generation, which would cause apnea leading to severe systemic hypoxemia and hypercapnia. 26 By definition, postmortem examinations of SUDEP cases reveal no identifiable cause of death. If, as we propose, seizure-induced brainstem hypoxia in respiratory centers is an underlying cause of SUDEP, failure to find a cause of death on postmortem examination is expected, since the global hypoxia that occurs in the brain following death would mask the local hypoxia that occurred in brainstem breathing centers. If SUDEP is the result of postictal hypoperfusion/hypoxia in brainstem breathing centers, pharmacologic prevention of local hypoxia could improve survival outcomes in animal models and ultimately in individuals at a high risk for SUDEP. Thus postictal hypoxia/hypoperfusion provides a novel neurobiologic target to explore as a possible mechanism of SUDEP.
Anatomic Alterations Following Repeated Seizures
One of the important implications of postictal vascular insufficiency is that researchers working with in vivo models or persons with epilepsy have actually been studying the combined effects of seizures and stroke-like events. This raises the question of whether it is the electrical event (seizure) itself or the downstream hypoperfusion/hypoxia event that is directly responsible for the anatomic alterations observed in brains from persons with epilepsy and in animal models. Noted changes in anatomy include the following: enhanced blood-brain barrier (BBB) permeability, 26, 27 formation of new capillaries, 28 central inflammation, 29 increased astrocyte size and count, 30 axonal sprouting, 17 and neuronal loss. 31, 32 Pathologic changes that occur in epilepsy also occur in ischemic stroke, and suggest a causal link in their development.
The BBB is a physical and metabolic barrier between the brain and the circulatory system. The barrier consists of endothelial cells that separate blood from extracellular fluid by tight junctions to restrict the passage of solutes. Seizures have been shown to result in a loss of these tight junctions, resulting in an increase in permeability of the BBB. 26, 27 Likewise, under ischemic stroke conditions decreased BBB tight junction integrity occurs. 33 This loss of tight junctions and increased permeability allows the passage of large molecules including immunoglobulins and albumin, which are thought to contribute to the epileptogenic process. 26, 34 Patients with temporal lobe epilepsy also have increased vessel density, which is positively correlated with seizure frequency. 27 Increased vessel density is also observed in human brains following ischemic stroke. 35 BBB insults are typically followed by an intense inflammatory response and the activation and proliferation of glial cells. This process, known as gliosis, is a common feature of several diseases and disorders including epilepsy. In accordance with our hypothesis that repeated seizure-induced hypoxic events could promote this pathologic phenomenon, gliosis commonly occurs following ischemia. 36 Astrocytes play key roles in BBB maintenance, metabolism, ion homeostasis, and neurotransmission in the healthy brain; however, these critical functions of astrocytes become impaired following both strokes and seizures. Reactive gliosis and a "glial scar" have been identified in the cortical periinfarct regions of human brains following ischemic stroke, and astrocyte proliferation and activation are a core feature of hippocampal sclerosis.
Changes in microglia are also seen following central nervous system (CNS) injury. Microglia are the brain-resident immune cells responsible for neuronal surveying, synaptic pruning, and phagocytosis. Microglial activation following ischemia results in massive changes in inflammatory signaling in the brain. High mobility group box 1 protein (HMGB1) is released from neurons during cellular stress, as seen during ischemic stroke. 37 HMGB1 can bind to receptors located on microglia, which can activate downstream pathways and exacerbate ischemic brain injury that leads to the production of other proinflammatory molecules like tumor necrosis factor a (TNFa) and interleukin (IL)-1b.
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HMBG1 and IL-1b are upregulated following seizures, and can activate Toll-like receptors on microglia. 39, 40 Given these similarities it is possible that repeated episodes of severe postictal hypoxia are responsible for these pathologic and immunologic changes in the brain.
Axonal sprouting occurs in many brain regions following seizures, but mossy fiber sprouting of dentate granule cell axons, originally reported by Sutula et al., 17 is particularly intense in the brains of persons with epilepsy and in animal models. Although mossy fiber sprouting has a controversial role in the development of epilepsy, 41 this anatomic change is also observed in stroke models. 42, 43 Thus it is possible that hypoxia is the common mechanism that drives axonal sprouting following stroke and seizures.
Neuronal cell death is common to seizure and ischemic stroke pathologies. The characteristic pathology of temporal lobe epilepsy is hippocampal sclerosis, a neuropathologic condition that results in severe neuronal cell loss and gliosis of the hippocampus. The supposed mechanism of neuronal death in epilepsy is often attributed to excitotoxicity where an excess of glutamatergic activity leads to an influx of calcium ions and subsequent activation of cell death pathways. 44 However, evidence of necrotic cell death and oxidative stress, typically associated with ischemic injury, has been implicated in seizure pathology. 45, 46 In light of this evidence, it is possible that classic hippocampal sclerosis may, in part, be mediated by hypoperfusion/hypoxiadependent neuronal death mechanisms.
The apparent overlap shared between seizure and stroke pathologies brings up the intriguing possibility that both are, in fact, mediated by hypoperfusion/hypoxia. Damage from stroke is often extremely severe and can lead to debilitating behavioral deficits. Many of these deficits are shared with individuals with epilepsy. Below we outline these interictal comorbidities and discuss their relationship to stroke-induced neurologic deficits.
Interictal Behavioral
Comorbidities (e.g., Depression, Anxiety, Memory deficits)
It is estimated that 30-50% of people with epilepsy experience a chronic comorbid condition. 47 Common psychiatric comorbidities include depression, anxiety disorders, psychosis, and cognitive dysfunction. 48 Although interictal comorbidities are common, the phenomenology of these conditions is not fully elucidated. The difficulty arises because interictal behavioral dysfunction lacks a clear temporal relation to seizures.
Interictal comorbidities likely develop as consequence of repeated ictal activity. Indeed, it has been reported that repeated seizure activity or interictal abnormal neuronal activity can be responsible for the disruption of physiologic brain oscillations and permanent alterations in synaptic plasticity. [49] [50] [51] [52] Interictal reductions in blood flow and metabolism in the epileptogenic and synaptically connected regions may be related to chronic hypoxia/hypoperfusion due to recurrent seizures. This may explain why the epileptic focus is hypoperfused and hypometabolic interictally. Moreover, as mentioned earlier, marked structural changes in the brain occur as result of repeated seizure activity and these may also be causally related to interictal comorbidities. 47 Several rodent studies have investigated the relationship between the extent of structural, morphologic, and physiologic alterations induced by seizure activity and the severity of psychiatric comorbidities with often contrasting results. [53] [54] [55] [56] [57] [58] Indeed, although some studies have reported correlations between cognitive and emotional alterations and the extent of anatomic lesions, [53] [54] [55] [56] others did not find any clear correlation between brain damage and behavioral alterations. 57, 58 Furthermore, cognitive and emotional alterations take place in two different rodent models of epilepsy, post-status epilepticus models of temporal lobe epilepsy and electrical kindling, which differ substantially in the degree of brain damage. 59, 60 In this context, prolonged hypoxia in the postictal period may be an important factor to explain discrepancies between behavioral and pathophysiologic outcomes. Indeed, several studies report that chronic cognitive and emotional disturbances can develop after a transient ischemic/hypoxic attack, [61] [62] [63] suggesting that the degree of the postictal hypoperfusion/hypoxia may be an important factor for the severity of comorbidities associated with seizures.
Evidence further indicates that interictal and postictal states are not independent but may influence one another, suggesting that they may share some underlying mechanisms. Most of our knowledge about this correlation derives from studies performed on epilepsy-related psychoses. Indeed, it has been reported that postictal psychosis increases the risk of developing interictal psychosis, [64] [65] [66] suggesting that postictal symptoms may endure and give rise to epilepsy-induced interictal behavioral disorders. Conversely, a history of mood disorders or interictal psychosis is associated with development of postictal psychosis. 67, 68 It is important to note that some interictal behavioral disturbances could be brief ictal events (subclinical) that may be followed by a hypoperfusion/hypoxic event. Indeed, interictal comorbidities can be subdivided into those that are chronic and dynamic, where the former are thought to occur primarily because of the underlying etiology of epilepsy, whereas the latter occur because of recurrent seizures or interictal spikes. 47 Different mechanisms have been postulated for alternating and dynamic seizurerelated psychosis, including alterations in cerebral blood flow, 4 thus suggesting a potential role of long-lasting hypoxia in interictal comorbidities.
Comorbidities represent a serious problem within the epilepsy population. Although interictal symptomology has been well studied, its exact mechanism and relationship to postictal symptomology and the underlying hypoperfusion/ hypoxia has yet to be established. Our postictal vascular insufficiency theory may explain how postictal events lead to long-term neuronal damage, thereby influencing longterm comorbidities in the interictal period.
Epileptogenesis
Approximately 20-30% of all epilepsies occur following an insult or trauma to the brain. 69 Eventually these damaging injuries induce cellular and structural reorganization that cause neurons to become hyperexcitable, ultimately leading to self-generating, recurrent seizures. This transition from initial injury to the first sign of a seizure is known as epileptogenesis. As we have discussed in the anatomy section, there is a process by which repeated episodes of seizure-induced hypoperfusion/hypoxia can promote further seizure activity because disruption of the BBB and increased angiogenesis, gliosis, axonal sprouting, and inflammation can all induce changes that render neuronal networks hyperexcitable. These alterations in brain anatomy and function, together with voxel-based morphometry studies in people with temporal lobe epilepsy, indicate that epilepsy is a progressive disorder that worsens with time. 70 Moreover, because seizures repeat and widely propagate to distant brain regions, postictal hypoperfusion/hypoxia may also become more widespread, lead to independent epileptogenesis, and thus contribute to secondary epileptogenesis in other brain regions. If so, then preventive treatments may help people with types of epilepsy and epilepsy-related dysfunction known to be related to secondary epileptogenesis. 71 Network reorganization from axonal sprouting and neuronal death is thought to contribute to epileptogenesis and is most studied in the dentate gyrus. Granule cells are under profound inhibition, and activation by entorhinal inputs is limited. 72 The dentate gyrus gates excitatory inputs to the hippocampus, and selectively compromising this gate leads to seizures. 73 Restoring this gate in epileptic mice inhibits seizures. 73 Thus stroke-induced or seizure-induced pathologies to this network-such as mossy-fiber sprouting, 30 granule cell to granule cell excitation, 72 mossy cell death, and loss of feed-forward inhibition 74 -may contribute to enhanced epileptogenesis. These alterations can sufficiently raise neural network excitability, lower seizure threshold, and promote the generation of seizures. Thus it is reasonable to hypothesize that if postictal hypoperfusion/hypoxia is exacerbating damage to the brain, then the blockade of this phenomenon will prevent anatomic changes and slow the epileptogenic process.
Clinical Implications
The previous sections have outlined animal and human data supporting our theory that postictal hypoperfusion/hypoxia is responsible for the negative consequences associated with seizures. Although the goal of clinicians caring for persons with epilepsy is the elimination of seizures, approximately 20-30% of patients have drug refractory epilepsy. 75 For these patients, the characterization and elimination of postictal hypoperfusion/hypoxia may reduce the negative consequences of seizures. With a small group of patients, Farrell et al. 7 showed that postictal hypoperfusion can be reliably measured using arterial spin-labeling MRI. Future studies should first focus on extending this observation to a larger group of patients in order to identify which patients are at greatest risk for exhibiting the most significant postictal hypoperfusion/hypoxia. Such studies could also correlate the extent of the postictal symptoms, interictal neurocognitive deficits, and behavioral comorbidities with the extent and location of postictal hypoperfusion. These studies could also identify which patient characteristics/features predispose them to more prominent postictal hypoperfusion/hypoxia. Identifying such patients is a critical first step and will form the necessary framework for patient selection for entry into clinical trials where the effect of widely available and safe COX-2 antagonists and L-type calcium channel blockers can be used to prevent postictal hypoperfusion. The effect of these agents on immediate postictal symptoms, interictal neurocognitive dysfunction, or behavioral comorbidities can also be assessed. Ultimately, if these clinical trials are fruitful, patients with drug refractory epilepsy can use readily available, inexpensive, and safe drugs to reduce the impact of seizures on their overall quality of life.
Conclusion
Although epilepsy has been conceived, correctly, as an electrical disorder, it is also a vascular disorder. This is not because ischemic/hypoxic attacks result in seizures, although they can, 16 but because seizures initiate a cascade of events that result in vasoconstriction, leading to hypoperfusion/hypoxia with its own set of neurologic consequences. The purpose of this Critical Review and Commentary is to convince the reader to also consider that seizures cause vascular insufficiency. Parenthetically, the theory should provide an opportunity for the two neurologic subdisciplines, epilepsy and stroke, to interact and learn from each other. Approaching seizure pathophysiology and behavioral dysfunction from a vascular insufficiency perspective could also open the door to novel treatment strategies for aspects of epilepsy that are currently untreated (e.g., Todd's paresis). We hope others will investigate seizure-induced vascular-related dysfunction as well as explore potential novel treatment strategies for people with seizures.
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